chr21-46112373-C-T

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_001849.4(COL6A2):​c.510C>T​(p.Cys170Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00497 in 1,606,742 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 24 hom. )

Consequence

COL6A2
NM_001849.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.782
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 21-46112373-C-T is Benign according to our data. Variant chr21-46112373-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 196330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46112373-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.782 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 24 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL6A2NM_001849.4 linkuse as main transcriptc.510C>T p.Cys170Cys synonymous_variant 3/28 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
COL6A2NM_058174.3 linkuse as main transcriptc.510C>T p.Cys170Cys synonymous_variant 3/28 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkuse as main transcriptc.510C>T p.Cys170Cys synonymous_variant 3/28 NP_478055.2 P12110-3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkuse as main transcriptc.510C>T p.Cys170Cys synonymous_variant 3/281 NM_001849.4 ENSP00000300527.4 P12110-1

Frequencies

GnomAD3 genomes
AF:
0.00336
AC:
510
AN:
151710
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00135
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.00348
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00233
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00493
Gnomad OTH
AF:
0.00527
GnomAD3 exomes
AF:
0.00342
AC:
796
AN:
233060
Hom.:
3
AF XY:
0.00359
AC XY:
463
AN XY:
128930
show subpopulations
Gnomad AFR exome
AF:
0.00139
Gnomad AMR exome
AF:
0.00214
Gnomad ASJ exome
AF:
0.000104
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00264
Gnomad FIN exome
AF:
0.00171
Gnomad NFE exome
AF:
0.00549
Gnomad OTH exome
AF:
0.00400
GnomAD4 exome
AF:
0.00514
AC:
7481
AN:
1454910
Hom.:
24
Cov.:
33
AF XY:
0.00515
AC XY:
3729
AN XY:
723656
show subpopulations
Gnomad4 AFR exome
AF:
0.000900
Gnomad4 AMR exome
AF:
0.00234
Gnomad4 ASJ exome
AF:
0.000154
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00259
Gnomad4 FIN exome
AF:
0.00211
Gnomad4 NFE exome
AF:
0.00608
Gnomad4 OTH exome
AF:
0.00413
GnomAD4 genome
AF:
0.00335
AC:
509
AN:
151832
Hom.:
0
Cov.:
32
AF XY:
0.00318
AC XY:
236
AN XY:
74238
show subpopulations
Gnomad4 AFR
AF:
0.00133
Gnomad4 AMR
AF:
0.00347
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00233
Gnomad4 FIN
AF:
0.00179
Gnomad4 NFE
AF:
0.00493
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.00447
Hom.:
2
Bravo
AF:
0.00348
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00605
EpiControl
AF:
0.00529

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024COL6A2: BP4, BP7, BS2 -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 17, 2020- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 06, 2015- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 26, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Myosclerosis Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Ullrich congenital muscular dystrophy 1A;C1850671:Myosclerosis;CN029274:Bethlem myopathy 1A Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 13, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
8.1
DANN
Benign
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142328765; hg19: chr21-47532287; COSMIC: COSV56003424; COSMIC: COSV56003424; API